Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults

T. G. Martin, J. L. Gajewski

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Acute lymphocytic leukemia remains a difficult disease to treat in adults. Allogeneic bone marrow transplantation can cure some patients with ALL, but GVHD transplant-related mortality and disease relapse remain problematic. Immunotherapeutic approaches aimed at eliminating minimal residual disease and enhancing the GVL effect may decrease relapse rates and improve overall survival. Because of the rarity of this disease in adults, every new patient should be entered in well-designed, peer-reviewed, investigational trial.

Original languageEnglish (US)
Pages (from-to)97-120
Number of pages24
JournalHematology/Oncology Clinics of North America
Volume15
Issue number1
DOIs
Publication statusPublished - 2001
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this